United States · FDA National Drug Code directory
Olanzapine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72603-155_bfaf4fef-69a8-40e1-b995-899044ad4a39
- Product NDC
- 72603-155
- Form
- TABLET, FILM COATED
- Composition / generic term
- Olanzapine
- Labeler
- NorthStar RxLLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20140822
- Source listing expiry
- 20261231
Source-listed ingredients
- OLANZAPINE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (72603-155-01) · 72603-155-01
- 90 TABLET, FILM COATED in 1 BOTTLE (72603-155-02) · 72603-155-02
- 1000 TABLET, FILM COATED in 1 BOTTLE (72603-155-03) · 72603-155-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →